Select Language
Free Registration
My Cart

CXCR5

CXCR5 Overview

English NameC-X-C motif chemokine receptor 5Approved Drugs0
Drugs in Clinical Trials2Target SynonymBurkitt Lymphoma Receptor 1， GTP-Binding Protein，C-X-C Motif Chemokine Receptor 5，Burkitt Lymphoma Receptor 1， GTP Binding Protein (Chemokine (C-X-C Motif) Receptor 5)，Chemokine (C-X-C Motif) Receptor 5，Monocyte-Derived Receptor 15，MDR-15，C-X-C Chemokine Receptor Type 5，Burkitt Lymphoma Receptor 1，CD185 Antigen，CXCR-5，CD185，MDR15，BLR1，CXCR5，CXC-R5，Receptors， CXCR5
Highest Development StagePhase 2 Clinical
English NameC-X-C motif chemokine receptor 5
Target SynonymBurkitt Lymphoma Receptor 1， GTP-Binding Protein，C-X-C Motif Chemokine Receptor 5，Burkitt Lymphoma Receptor 1， GTP Binding Protein (Chemokine (C-X-C Motif) Receptor 5)，Chemokine (C-X-C Motif) Receptor 5，Monocyte-Derived Receptor 15，MDR-15，C-X-C Chemokine Receptor Type 5，Burkitt Lymphoma Receptor 1，CD185 Antigen，CXCR-5，CD185，MDR15，BLR1，CXCR5，CXC-R5，Receptors， CXCR5
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

CXCR5 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (3)

  • Tag

    - (1)His Tag & Flag Tag (2)

  • Conjugate

    Unconjugated (3)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
CX5-H51D3
Human
E. coli
Human CXCR5 Full Length Protein, His,Flag Tag (Detergent)
 Add to Cart
CX5-H52D6
Human
HEK293
Human CXCR5 Protein, Flag,His Tag (Detergent)
 Add to Cart
CX5-H52P4
Human
HEK293
Human CXCR5 Full Length Protein (VLP) Add to Cart
Total: 3
  • 1

CXCR5 Background

Cytokine receptor that binds to B-lymphocyte chemoattractant (BLC). Involved in B-cell migration into B-cell follicles of spleen and Peyer patches but not into those of mesenteric or peripheral lymph nodes. May have a regulatory function in Burkitt lymphoma (BL) lymphomagenesis and/or B-cell differentiation.

CXCR5 Synonyms

BLR1, CD185, MDR15

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
PF-06835375PF-06835375Phase 2 ClinicalPfizer IncArthritis, Rheumatoid; Lupus Erythematosus, Systemic; Lupus Vulgaris; Purpura, Thrombocytopenic, Idiopathic
Details
CXCR5 Modified EGFR Chimeric Antigen Receptor Autologous T Cell TherapyPhase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical UniversityCarcinoma, Non-Small-Cell Lung
Details
  • Overview
  • Product List
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland